G
Galectin Therapeutics Inc.
GALT · NASDAQ · Healthcare · 227M
Price · close
$3.68
+3.08% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-15.0×
Free cash flow yieldFCF yield
-10.2%
Return on equityROE
24.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
-4.9×
Interest coverage
-2.7×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.